Replimune Group, Inc. (REPL)

7.04 -0.26 (-3.56%) USD  |  NASDAQ  |  Jan 16, 16:00
7.18 +0.14 (+1.99%) After-Hours: 20:00
More

Replimune Group Total Long Term Liabilities (Quarterly)

Total Long Term Liabilities (Quarterly) Chart

View Total Long Term Liabilities (Quarterly) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Liabilities (Quarterly) Range, Past 5 Years

View Total Long Term Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Liabilities (Quarterly) Benchmarks

View Total Long Term Liabilities (Quarterly) Benchmarks
Start Trial
Rapt Therapeutics, Inc. --
Olema Pharmaceuticals, Inc. --
CorMedix, Inc. Upgrade
Verastem, Inc. --
Anavex Life Sciences Corp. --